JCR
Desconocido
COVID-RED: COVID 19 infections Remote Early Detection
JULIUS CLINICAL RESEARCH BV
participó en un
H2020:
H2020-JTI-IMI2-2020-21-single-stage
In this project, we will evaluate the use and performance of a CE-marked device (wearable), which uses sensors to measure breathing rate, pu...
2020-10-16 - 2022-12-31 | Financiado
2020-10-16 - 2022-12-31 | Financiado
Trials@Home: Trials@Home Center of Excellence Remote Decentralised Clinical Trials
JULIUS CLINICAL RESEARCH BV
participó en un
H2020:
H2020-JTI-IMI2-2018-14-two-stage
Clinical trials increase in size, complexity and costs. This is fuelled with the need to demonstrate effects in more complex therapeutic are...
2019-08-07 - 2025-11-30 | Financiado
2019-08-07 - 2025-11-30 | Financiado
PREFERABLE: Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life
JULIUS CLINICAL RESEARCH BV
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Despite the tremendous improvement in early diagnosis and treatment of breast cancer, a large proportion (up to 40%) of patients with breast...
2018-12-03 - 2024-06-30 | Financiado
2018-12-03 - 2024-06-30 | Financiado
PIONEER: Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope
JULIUS CLINICAL RESEARCH BV
participó en un
H2020:
H2020-JTI-IMI2-2016-10-two-stage
Prostate Cancer (PCa) is the second leading cause of cancer, among men in Europe. There are currently major unmet needs in this field, such...
2018-06-14 - 2023-10-31 | Financiado
2018-06-14 - 2023-10-31 | Financiado
CONVINCE: The Comparison of High Dose Heamodiafiltration HDF versus Haemodialyse
JULIUS CLINICAL RESEARCH BV
participó en un
H2020:
H2020-SC1-2016-2017
End stage kidney disease ranks among the most severe chronic non-communicable diseases with an unmet medical need, given the high (between 1...
2017-12-05 - 2023-12-31 | Financiado
2017-12-05 - 2023-12-31 | Financiado
HIT-CF: Personalised Treatment For Cystic Fibrosis Patients With Ultra rare CFTR Mutations and beyond
JULIUS CLINICAL RESEARCH BV
participó en un
H2020:
H2020-SC1-2016-2017
In our HIT-CF project, we aim to bring personalised disease modifying therapies to cystic fibrosis (CF) patients with ultra-rare CFTR mutati...
2017-11-28 - 2025-06-30 | Financiado
2017-11-28 - 2025-06-30 | Financiado
COMBACTE-NET: Combatting Bacterial Resistance in Europe
JULIUS CLINICAL RESEARCH BV
participó en un
FP6:
The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified...
2013-01-01 - 2021-02-28 | Financiado
2013-01-01 - 2021-02-28 | Financiado
COMBACTE-NET: Combatting Bacterial Resistance in Europe
JULIUS CLINICAL RESEARCH BV
participó en un
FP7:
The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified...
Financiado
Financiado
* No se disponen de datos de la empresa actual.